Cargando…
Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis
BACKGROUND: Glioblastoma (GBM) is one of the most common and aggressive primary malignant brain tumors with severe symptoms and a poor prognosis. Leptomeningeal dissemination (LMD) is a serious complication of GBM that often results in dire outcomes. There is currently no effective treatment. AIM: T...
Autores principales: | Kang, Xun, Chen, Feng, Yang, Shou-Bo, Wang, Ya-Li, Qian, Zeng-Hui, Li, Yan, Lin, Hao, Li, Parker, Peng, Yi-Chen, Wang, Xiao-Min, Li, Wen-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258364/ https://www.ncbi.nlm.nih.gov/pubmed/35979103 http://dx.doi.org/10.12998/wjcc.v10.i17.5595 |
Ejemplares similares
-
Methotrexate myelopathy after intrathecal chemotherapy: a case report
por: Murata, Ken-ya, et al.
Publicado: (2015) -
Glioblastoma Multiforme in the Pineal Region with Leptomeningeal Dissemination and Lumbar Metastasis
por: Matsuda, Ryosuke, et al.
Publicado: (2015) -
SDPS-16 CYTOLOGIC AND SEROLOGIC RESPONSE WITH INTRATHECAL METHOTREXATE IN A PATIENT WITH LEPTOMENINGEAL CARCINOMATOSIS FROM OVARIAN CANCER
por: Cordova, Christine, et al.
Publicado: (2023) -
Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single‐arm study
por: Pan, Zhenyu, et al.
Publicado: (2016) -
A Retrospective Study of Intrathecal Pemetrexed Combined With Systemic Therapy for Leptomeningeal Metastasis of Lung Cancer
por: Geng, Di, et al.
Publicado: (2022)